Preclinical development of virus-like particle (VLP)-based immunotherapy against HDM allergy von Patniboon, Piyachat, Thanasarnthungcharoen, Chanatip, Chanasit, Supapich, Fievez, Laurence, Kaewamatawong, Theerayuth, Bureau, Fabrice, Jacquet, Alain

Volltext

Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation von Thanasarnthungcharoen, Chanatip, Chanasit, Supapich, Fievez, Laurence, Kaewamatawong, Theerayuth, Patniboon, Piyachat, Lin, Paulo J. C., Bureau, Fabrice, Jacquet, Alain

Volltext

Hypoallergenic chimeric virus‐like particles for the development of shrimp tropomyosin allergen Pen m 1‐specific blocking antibodies von Chanasit, Supapich, Johnston, Elecia, Thanasarnthungcharoen, Chanatip, Kamath, Sandip D., Bohle, Barbara, Lopata, Andreas L., Jacquet, Alain

Volltext

Nucleoside‐modified mRNA vaccines yield robust blocking antibody responses against major house dust mite allergens von Jitthamstaporn, Sirikarn, Inthong, Rueangsit, Audomsun, Dittaya, Chanasit, Supapich, Thanasarnthungcharoen, Chanatip, Lin, Paulo J. C., Weissman, Drew, Pardi, Norbert, Jacquet, Alain

Volltext